Anita Nelsen
President, Clinical Trial Operations
Clinical Development
Strategy, solutions and insights to navigate the complexities of drug development
Anchored by deep expertise and a high-touch partnership model, Allucent delivers operational excellence across a breadth of specialized services and therapeutic experience geared toward small and mid-sized biotech companies.
Allucent’s flexible clinical development and regulatory solutions enable our partners to successfully navigate the complexities of managing and conducting early and late-stage multi-national programs through dedicated study start-up and patient engagement teams, tailored onsite, hybrid or DCT clinical monitoring, full-service pharmacovigilance, data management and biometric capabilities, and medical monitoring.
Our global workforce possesses deep clinical and technical experience coupled with a passion for innovative breakthrough science and assisting clients in delivering novel treatments to patients.
Therapeutic Expertise
Allucent provides robust scientific and drug development expertise for complex therapeutic areas, modalities, and devices, with a focus on oncology, neuroscience, infectious disease and vaccines, cell and gene therapy, and rare diseases.
Clinical Strategy
Our clinical strategy services span design and execution of full product development programs, from exploratory IND and first-in-human to IND (or equivalent), clinical development, marketing approval, through to Phase IV post-marketing research.
Study Start-Up & Site Intelligence
We work as your strategic and operational partner to optimize your study recruitment. Our holistic approach enhances site intelligence, thereby increasing confidence in site identification and selection, expediting the start of studies and enabling earlier patient enrollment.
Patient Recruitment & Retention
Our dedicated Patient Engagement team offers tailored strategies to support patient recruitment, engagement, diversity and compliance, working across a range of therapeutic areas and clinical study types, including on-site, decentralized, and hybrid trials.
Study Experience
1015+
clinical trials conducted
Trials in
75+
countries worldwide
825+
regulatory submissions per year
50+
approved and marketed products
Meet Your A-Team
- Over 30 years of experience in the clinical trial sphere
- Deep expertise in the application of human and molecular genetics and genomics in disease research, drug discovery, and global drug development
- Comprehensive experience in all aspects of global clinical pharmacology studies, including project management, clinical operations, and wrap around services
Angela D. Brady, MHL
SVP, Project Leadership and Client Relations
- Seasoned professional with 25+ years of experience in the field of clinical research
- Strategic and adaptable leader skilled in managing complex and diverse enterprises and alliances across different therapeutic areas and stages of development
- End-to-end translational and therapeutic leadership from the preclinical stage to commercialization for a multitude of indications, including oncology, hematology, rare/orphan disease, neurology, and medical device
Joyce Moore, PhD
Global Head,
Patient Engagement
- Over 20 years of experience in the clinical trial sphere
- Deep expertise in patient engagement including conducting DCTs and collaborating with patient advocacy groups
Christine Khoza
Global Head, Study Start-up & Site Intelligence
- 10+ years of experience in clinical trial operations
- Offers expert guidance on study startup and site intelligence on a global scale
